ZURZUVAE

This brand name is authorized in United States

Active ingredients

The drug ZURZUVAE contains one active pharmaceutical ingredient (API):

1 Zuranolone
UNII 7ZW49N180B - ZURANOLONE

The mechanism of action of zuranolone in the treatment of postpartum depression is not fully understood, but is thought to be related to its positive allosteric modulation of GABAA receptors.

Read about Zuranolone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZURZUVAE Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 64406-029, 64406-030, 64406-031

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈